Thermo Fisher Scientific Operating Income remained flat by 0.0% to $1.94B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from $2.02B to $1.94B. Over 4 years (FY 2021 to FY 2025), Operating Income shows a downward trend with a -6.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in operating income suggests that the company is becoming more profitable in its primary business activities.
The profit realized from a business's own operations after deducting all operating expenses, including COGS, R&D, and SG...
This is a key metric for comparing the operational performance of companies with different debt levels.
is_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.16B | $2.28B | $2.54B | $2.82B | $2.00B | $1.71B | $1.86B | $1.56B | $1.58B | $1.86B | $1.85B | $1.66B | $1.82B | $1.84B | $2.02B | $1.94B | $1.94B | $1.94B | $1.94B |
| QoQ Change | — | +5.3% | +11.4% | +11.2% | -29.1% | -14.5% | +8.8% | -16.0% | +1.0% | +18.1% | -0.5% | -10.3% | +9.4% | +1.0% | +9.7% | -3.9% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -7.5% | -24.9% | -26.7% | -44.6% | -21.1% | +9.0% | -0.4% | +6.4% | +15.3% | -1.4% | +8.7% | +16.4% | +6.4% | +5.4% | -3.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.